158 related articles for article (PubMed ID: 3280120)
1. Potential intracellular target proteins of the anticarcinogenic Bowman Birk protease inhibitor identified by affinity chromatography.
Billings PC; St Clair W; Owen AJ; Kennedy AR
Cancer Res; 1988 Apr; 48(7):1798-802. PubMed ID: 3280120
[TBL] [Abstract][Full Text] [Related]
2. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor.
Billings PC; Habres JM; Liao DC; Tuttle SW
Cancer Res; 1991 Oct; 51(20):5539-43. PubMed ID: 1913672
[TBL] [Abstract][Full Text] [Related]
3. Proteases occurring in the cell membrane: a possible cell receptor for the Bowman-Birk type of protease inhibitors.
Yavelow J; Caggana M; Beck KA
Cancer Res; 1987 Mar; 47(6):1598-601. PubMed ID: 3545448
[TBL] [Abstract][Full Text] [Related]
4. A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor.
Billings PC; Habres JM
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3120-4. PubMed ID: 1557421
[TBL] [Abstract][Full Text] [Related]
5. Internalisation of the Bowman-Birk protease inhibitor by intestinal epithelial cells.
Billings PC; Brandon DL; Habres JM
Eur J Cancer; 1991; 27(7):903-8. PubMed ID: 1834126
[TBL] [Abstract][Full Text] [Related]
6. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
Chen YW; Huang SC; Lin-Shiau SY; Lin JK
Carcinogenesis; 2005 Jul; 26(7):1296-306. PubMed ID: 15746161
[TBL] [Abstract][Full Text] [Related]
7. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
Wan XS; Serota DG; Ware JH; Crowell JA; Kennedy AR
Nutr Cancer; 2002; 43(2):167-73. PubMed ID: 12588697
[TBL] [Abstract][Full Text] [Related]
8. Imbibition of soybean seeds in warm water results in the release of copious amounts of Bowman-Birk protease inhibitor, a putative anticarcinogenic agent.
Palavalli MH; Natarajan SS; Wang TT; Krishnan HB
J Agric Food Chem; 2012 Mar; 60(12):3135-43. PubMed ID: 22372424
[TBL] [Abstract][Full Text] [Related]
9. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor.
St Clair WH; Billings PC; Carew JA; Keller-McGandy C; Newberne P; Kennedy AR
Cancer Res; 1990 Feb; 50(3):580-6. PubMed ID: 2297699
[TBL] [Abstract][Full Text] [Related]
10. Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum.
Kennedy CW; Donahue JJ; Wan XS
Nutr Cancer; 1996; 26(2):209-17. PubMed ID: 8875558
[TBL] [Abstract][Full Text] [Related]
11. Prevention of carcinogenesis by protease inhibitors.
Kennedy AR
Cancer Res; 1994 Apr; 54(7 Suppl):1999s-2005s. PubMed ID: 8137328
[TBL] [Abstract][Full Text] [Related]
12. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells.
Ware JH; Wan XS; Kennedy AR
Nutr Cancer; 1999; 33(2):174-7. PubMed ID: 10368813
[TBL] [Abstract][Full Text] [Related]
13. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
Zhang L; Wan XS; Donahue JJ; Ware JH; Kennedy AR
Nutr Cancer; 1999; 33(2):165-73. PubMed ID: 10368812
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory properties and solution structure of a potent Bowman-Birk protease inhibitor from lentil (Lens culinaris, L) seeds.
Ragg EM; Galbusera V; Scarafoni A; Negri A; Tedeschi G; Consonni A; Sessa F; Duranti M
FEBS J; 2006 Sep; 273(17):4024-39. PubMed ID: 16889634
[TBL] [Abstract][Full Text] [Related]
15. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans.
Maki PA; Paterson Y; Kennedy AR
Nutr Cancer; 1994; 22(2):185-93. PubMed ID: 14502847
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
[TBL] [Abstract][Full Text] [Related]
17. Bowman-Birk protease inhibitor activates DNA-dependent protein kinase and reduces formation of radiation-induced dicentric chromosomes.
Dittmann K; Virsik-Köpp P; Mayer C; Rave-Fränk M; Rodemann HP
Int J Radiat Biol; 2003 Oct; 79(10):801-8. PubMed ID: 14630539
[TBL] [Abstract][Full Text] [Related]
18. Antiapoptotic activity of the Bowman-Birk inhibitor can be attributed to copurified phospholipids.
Foehr MW; Tomei LD; Goddard JG; Pemberton PA; Bathurst IC
Nutr Cancer; 1999; 34(2):199-205. PubMed ID: 10578488
[TBL] [Abstract][Full Text] [Related]
19. Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor.
Kennedy AR; Beazer-Barclay Y; Kinzler KW; Newberne PM
Cancer Res; 1996 Feb; 56(4):679-82. PubMed ID: 8630994
[TBL] [Abstract][Full Text] [Related]
20. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.
Malkowicz SB; Liu SP; Broderick GA; Wein AJ; Kennedy AR; Levin RM
Neurourol Urodyn; 2003; 22(1):54-7. PubMed ID: 12478602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
